SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA

被引：0
|
作者：
Vogelberg, C. [1 ]
Szefler, S. J. [2 ,3 ]
Hamelmann, E. [4 ,5 ]
Boner, A. [6 ]
Moroni-Zentgraf, P. [7 ]
Engel, M. [7 ]
El Azzi, G. [7 ]
Finnigan, H. [8 ]
Vandewalker, M. [9 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[2] Childrens Hosp Colorado, Dept Paediat, Aurora, CO USA
[3] Univ Colorado Denver, Sch Med, Aurora, CO USA
[4] Evangel Krankenhaus Bielefeld, Bochum, Germany
[5] Ruhr Univ, Allergy Ctr, Bochum, Germany
[6] Univ Verona, Dept Paediat, Verona, Italy
[7] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[8] Boehringer Ingelheim Ltd, Biostat & Data Sci, Bracknell, Berks, England
[9] Ozarks Inc, Clin Res, Columbia, MO USA
来源：
THORAX | 2016年 / 71卷
关键词：
INHALED CORTICOSTEROIDS;
D O I：
10.1136/thoraxjnl-2016-209333.298
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P155
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 50 条
  • [31] Safety And Tolerability Of Once-Daily Tiotropium Respimat® Add-On Therapy In African-American Patients With Symptomatic Persistent Asthma Across A Range Of Severities
    Graham, L. M.
    Kerstjens, H. A. M.
    Vogelberg, C.
    Hamelmann, E.
    Szefler, S. J.
    Voelker, B.
    Engel, M.
    Unseld, A.
    Foggs, M. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [32] Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status
    Yang W.H.
    Casale T.
    Bateman E.D.
    Dahl R.
    Pizzichini E.
    Vandewalker M.
    Virchow J.C.
    Engel M.
    Moroni-Zentgraf P.M.
    Schmidt H.
    Kerstjens H.A.M.
    Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
  • [33] TIOTROPIUM RESPIMAT® ADD-ON THERAPY IMPROVES LUNG FUNCTION, AS MEASURED BY PEAK EXPIRATORY FLOW, IN ADULT PATIENTS ACROSS SEVERITIES OF SYMPTOMATIC ASTHMA
    Doherty, Dennis
    Castro, Mario
    Moroni-Zentgraf, Petra
    Engel, Michael
    Luehmann, Reinhold
    Buhl, Roland
    RESPIROLOGY, 2015, 20 : 16 - 16
  • [34] 24-HOUR LUNG FUNCTION RESPONSE TO TIOTROPIUM RESPIMAT® ADD-ON TO MAINTENANCE THERAPY IN SYMPTOMATIC PATIENTS WITH MODERATE PERSISTENT ASTHMA.
    Casale, T.
    Carr, W. W.
    Greos, L.
    Engel, M.
    Bour, L. J.
    Moroni-Zentgraf, P.
    Kerstjens, H. A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A108 - A108
  • [35] Tiotropium Respimat® Add-On Therapy Reduces Exacerbation Risk In Patients With Symptomatic Moderate To Severe Asthma, Independent Of T Helper 2 Status
    Casale, T. B.
    Dahl, R.
    Virchow, J. C.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H. A. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Once-daily tiotropium respimat add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [37] TIOTROPIUM RESPIMAT® ADD-ON THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH SYMPTOMATIC MODERATE TO SEVERE ASTHMA, INDEPENDENT OF T HELPER 2 STATUS
    Philips, M.
    Casale, T.
    Dahl, R.
    Virchow, J.
    Engel, M.
    Moroni-Zentgraf, P.
    Luehmann, R.
    Kerstjens, H.
    RESPIROLOGY, 2016, 21 : 107 - 107
  • [38] ONCE-DAILY TIOTROPIUM RESPIMAT® ADD-ON TO AT LEAST ICS MAINTENANCE THERAPY REDUCES EXACERBATION RISK IN PATIENTS WITH UNCONTROLLED SYMPTOMATIC ASTHMA
    Doherty, Dennis E.
    Halpin, David
    Bateman, Eric
    Paggiaro, Pierluigi
    Bleecker, Eugene
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib Am
    RESPIROLOGY, 2015, 20 : 5 - 5
  • [39] Tiotropium Respimat® Add-On Therapy Reduces Airflow Obstruction In Patients With Symptomatic Moderate Asthma, Independent Of TH2 Inflammatory Status
    Casale, Thomas B.
    Bateman, Eric Donn
    Dahl, Ronald
    Pizzichini, Emilio
    Vandewalker, Mark L.
    Virchow, Johann Christian
    Engel, Michael
    Moroni-Zentgraf, Petra
    Schmidt, Hendrik
    Kerstjens, Huib A. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB5 - AB5
  • [40] Tiotropium Respimat® Add-On Therapy Improves Lung Function, As Measured By Peak Expiratory Flow, In Adult Patients Across Severities Of Symptomatic Asthma
    Doherty, D. E.
    Castro, M.
    Moroni-Zentgraf, P.
    Engel, M.
    Luehmann, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345